Aurora Cannabis, Aphria Said To Have Walked From Potential Merger Over Executive Compensation

It’s been reported by BNN Bloomberg that Aphria Inc (TSX: APHA) (NASDAQ: APHA) and Aurora Cannabis (TSX: ACB) (NYSE: ACB) recently explored the topic of a merger, whereby Aphria would become the majority holder of the resulting issuer. The report from Bloomberg comes weeks after Twitter user @BettingBruiser originally reported on the matter.

Unsurprising to investors in Canadian potstocks, BNN has reported that discussions broke down not because of perceived value to shareholders, but rather over the topic of executive compensation along with board composition. Discussions for the merger reportedly took place over the course of several weeks before finally breaking down last week. It’s unclear if discussions are continuing between the two firms at this time.

Prior to the breakdown of merger discussions, Aphria was said to be the majority holder in the resulting issuer, with current shareholders set to receive 51% of the resulting company while Aurora shareholders would own 49%. Given this fact, current Aphria CEO Irwin Simon is said to have been the selected head of the resulting issuer. Compensation to shareholders was planned to be provided via a share swap, rather than that of an all cash transaction, however the exchange rate was not disclosed.

If the transaction were to have closed, the resulting issuer would have been valued at roughly $3.5 billion while representing approximately 30% of all recreational cannabis sales in the country. $200 million in costing synergies were said to have already been found between the two issuers, while having combined annual revenue in excess of $800 million.


Information for this briefing was found via BNN Bloomberg. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

One Response

  1. If the merger goes through what will happened with Aurora Warrants exercising date 2ND OF NOVEMBER 2020 with an exercise price of $ 40.00. CAD .

Video Articles

Why the Market May Be Misreading Iran | David Woo

Why US Fertilizer Supply Could Matter a Lot More Now | Pat Varas – Sage Potash

Roscan Gold: Mali Discount Hits Kandiole PEA

Recommended

Silver47 Kicks Off 7,000-Meter Drill Campaign at Nevada’s Hughes Project

CBS News Cuts Staff and Shuts Radio Network in Early Bari Weiss Era

Related News

Aurora Cannabis Cuts Losses As It Continues To Hunt For Savings

Aurora Cannabis (TSX: ACB) has trimmed its net loss by $590.4 million in the latest...

Friday, August 11, 2023, 09:02:49 AM

Aurora Cannabis: What Happened?

Terry Booth’s Thursday departure from the C suite at Aurora Cannabis (TSX: ACB) (NYSE: ACB)...

Sunday, February 9, 2020, 08:00:00 AM

Aphria Enters Polish Market Via Arrangement With ODI Pharma AB

It appears that Aphria Inc (TSX: APHA) (NASDAQ: APHA) is expanding its distribution to Poland....

Monday, November 2, 2020, 11:16:06 AM

Aurora Cannabis Sued By CTT Pharma Over Denial Of Contractual Commitments

It seems Aurora Cannabis (TSX: ACB) (NYSE: ACB) has found itself in some hot water....

Thursday, August 27, 2020, 08:01:37 AM

Stifel Downgrades Aurora Cannabis Price Target To $3.60 Based On Liquidation Analysis

This morning, Stifel downgraded their 12-month price target on Aurora Cannabis (TSX: ACB) (NYSE: ACB)...

Wednesday, October 28, 2020, 10:59:00 AM